Screening compound: XWHBBPZHRUKVBI-UHFFFAOYSA-N

Screening compound: XWHBBPZHRUKVBI-UHFFFAOYSA-N
Screening compound: XWHBBPZHRUKVBI-UHFFFAOYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
XWHBBPZHRUKVBI-UHFFFAOYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P510-0228

Molecular Formula

C24H32N6O2 (C24 H32 N6 O2)

Compound Name

4-{6-[4-(4-phenylpiperazine-1-carbonyl)piperidin-1-yl]pyrimidin-4-yl}morpholine

IUPAC name

4-{6-[4-(4-phenylpiperazine-1-carbonyl)piperidin-1-yl]pyrimidin-4-yl}morpholine

SMILES

O=C(C(CC1)CCN1c1ncnc(N2CCOCC2)c1)N(CC1)CCN1c1ccccc1

InChI

InChI=1S/C24H32N6O2/c31-24(30-12-10-27(11-13-30)21-4-2-1-3-5-21)20-6-8-28(9-7-20)22-18-23(26-19-25-22)29-14-16-32-17-15-29/h1-5,18-20H,6-17H2

InChI Key

XWHBBPZHRUKVBI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27577795

XWHBBPZHRUKVBI-UHFFFAOYSA-N in Drug Discovery

Included in Screening Libraries

Autophagy-Targeted Library (4564 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

PI3K-Targeted Library (17255 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with XWHBBPZHRUKVBI-UHFFFAOYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound XWHBBPZHRUKVBI-UHFFFAOYSA-N?
Check Price and Availability of XWHBBPZHRUKVBI-UHFFFAOYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of XWHBBPZHRUKVBI-UHFFFAOYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for XWHBBPZHRUKVBI-UHFFFAOYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for XWHBBPZHRUKVBI-UHFFFAOYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of XWHBBPZHRUKVBI-UHFFFAOYSA-N available by request